Europe kicked off 2026 by adding more brains to the vaccine bureaucracy, designating a new WHO Collaborating Centre to help NITAGs turn messy evidence into cleaner policy decisions. In theory, this means fewer hand‑wavy...
Evidence from leading journals since 2021 consistently documents both pronounced vaccine inequity between countries and substantial within‑country access gaps, especially for COVID‑19 but also for routine childhood...
In the last days, there have been notable developments in COVID‑19 vaccine formulations, WHO prequalification, and – as reported before – politically driven schedule changes in the US. Very recent product...
WHO’s vaccination work represents one of the clearest examples of sustained, science‑based global cooperation in public health, and the attached summary illustrates how far‑reaching and internally coherent this effort...
In short: Classic vaccines have picked most of the low-hanging fruit: stable-antigen pathogens tamed by robust neutralizing antibodies, leaving the real fun to TB, HIV and other shape-shifters that demand sophisticated...
We are aware of two vaccines in late clinical development (Phase 2 completed) globally to address a significant medical need for pregnant women and their offspring, one from Pfizer in the United States and one from...
In the wake of the COVID19 pandemic and the evolution of mRNA vaccines, the global vaccine industry in 2025 is characterized by rapid expansion of manufacturing capacity, especially for mRNA and other novel platforms...
Question: I received Zostavax 10 years ago. Can I now get vaccinated with Shingrix? Answer: Yes. The Evidence. The study referenced below shows that the Shingrix is immunogenic and well-tolerated in older adults who had...
The World Health Organization provides a detailed report on the Ebola virus disease (EVD) outbreak that occurred in the Bulape Health Zone of Kasai Province, Democratic Republic of the Congo (DRC), in 2025. The Ministry...
In a NEJM Perspective, 12 former FDA commissioners warn that new internal FDA directives on vaccine regulation threaten evidence‑based policy, innovation, and public health. The piece responds to a memo by the current...